Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

31.12B

Market cap31.12B

Price-Earnings ratio

12.22

Price-Earnings ratio12.22

Dividend yield

2.81%

Dividend yield2.81%

Average volume

4.27M

Average volume4.27M

High today

$75.89

High today$75.89

Low today

$74.25

Low today$74.25

Open price

$74.70

Open price$74.70

Volume

3.94M

Volume3.94M

52 Week high

$148.30

52 Week high$148.30

52 Week low

$68.77

52 Week low$68.77

Stock Snapshot

With a market cap of 31.12B, Zoetis(ZTS) trades at $75.29. The stock has a price-to-earnings ratio of 12.22 and currently yields dividends of 2.81%.

During the trading session on 2026-10-14, Zoetis(ZTS) shares reached a daily high of $75.89 and a low of $74.25. At a current price of $75.29, the stock is +1.4% higher than the low and still -0.8% under the high.

Trading volume for Zoetis(ZTS) stock has reached 3.94M, versus its average volume of 4.27M.

The stock's 52-week range extends from a low of $68.77 to a high of $148.30.

ZTS News

Simply Wall St 16h

Zoetis Stock May Sit Below Fair Value After Mixed Q2 Results

has seen its share price weaken materially in recent years, and with earnings now in the spotlight, the question is whether the current valuation still lines up...

TipRanks 2d

Zoetis Appoints Iris Knobloch to Board of Directors

The latest update is out from Zoetis ( (ZTS) ). On October 8, 2026, Zoetis’ board appointed Iris Knobloch as a director, effective December 1, 2026, expanding...

The Motley Fool 5d

A Once-in-a-Decade Opportunity: 2 Magnificent Dividend Stocks Down 34% to 52% I'm Buying Right Now

Though the S&P 500 remains near an all-time high, many steady-Eddie dividend stocks have not gone along for the ride. In fact, many of these top-tier dividend g...

Analyst ratings

67%

of 18 ratings

Buy

33.3%

Hold

66.7%

Sell

More ZTS News

Simply Wall St 6d

Zoetis Gets A Fresh Heartworm Boost While Fair Value Stays In Focus

Advertisement Why Zoetis is back on investors’ radar Fresh peer reviewed data on Simparica Trio has put Zoetis (ZTS) in focus, showing stronger protection aga...

TipRanks 6d

Zoetis put volume heavy and directionally bearish

Bearish flow noted in Zoetis (ZTS) with 2,293 puts trading, or 1.3x expected. Most active are Mar-27 50 puts and Mar-27 65 puts, with total volume in those stri...

Simply Wall St 7d

Heartworm Study Results Change The Bull Case For Zoetis Stock?

Zoetis recently reported peer reviewed data in Parasites & Vectors showing Simparica Trio achieved 99.5% efficacy against a macrocyclic lactone resistant heartw...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.